Answers are grounded in this paper and cite their sources.
mice before BCG infection prevented manifestations of severe BCG disease and maintained lung and spleen organ integrity, which was accompanied by a reduced mycobacterial burden in lung and spleen and a prolonged overall survival in animals that received a transplant. In summary, we demonstrate an HSC-based gene therapy approach for IFNγR1 deficiency, which protects mice from severe mycobacterial infections, thereby laying the foundation for a new therapeutic intervention in corresponding human patients.
No takes yet. Share an insight, caveat, or question.
Hetzel et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: